AAM
ARNA

Alpine Associates Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Alpine Associates Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-806,200
Closed -$74.9M – 60
2021
Q4 		$74.9M Buy
+806,200
New +$53.1M 2.8% 13

Alpine Associates Management's ARNA Position: Q1 2022 in Review

Alpine Associates Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 806,200 shares — an estimated $74.9M sold.

Alpine Associates Management first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $74.9M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Alpine Associates Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Alpine Associates Management sold 806,200 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $74.9M.
  • Alpine Associates Management first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
  • Alpine Associates Management's Arena Pharmaceuticals Inc position peaked at $74.9M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Alpine Associates Management's 13F filing for Q1 2022, filed 11 May 2022.